ライフサイエンスコーパス: transesophageal echocardiography

1 ere remains diagnostic uncertainty following transesophageal echocardiography.

2 ight ventricular function was assessed using transesophageal echocardiography.

3 40) and similar in patients with and without transesophageal echocardiography.

4 e thickness and morphology were evaluated by transesophageal echocardiography.

5 contrast opacification, and when indicated, transesophageal echocardiography.

6 others, can all be reliably performed using transesophageal echocardiography.

7 further paved the way to the application of transesophageal echocardiography.

8 myocardial biopsies were performed guided by transesophageal echocardiography.

9 lic areas of the left ventricle by utilizing transesophageal echocardiography.

10 al biopsies (2 per patient) were obtained by transesophageal echocardiography.

11 line), and mitral competence was assessed by transesophageal echocardiography.

12 pulation, were examined by transthoracic and transesophageal echocardiography.

13 dysfunction during bypass surgery, guided by transesophageal echocardiography.

14 LA pressure measurements and intraoperative transesophageal echocardiography.

15 potential cardioembolic source detected with transesophageal echocardiography.

16 te to severe TR underwent 3-dimensional (3D) transesophageal echocardiography.

17 ith a right-to-left shunt was confirmed with transesophageal echocardiography.

18 motion and stroke volume were monitored via transesophageal echocardiography.

19 han IVC and PP, but its measurement requires transesophageal echocardiography.

20 ypertrophic cardiomyopathy by intraoperative transesophageal echocardiography.

21 phageal echocardiography, and specificity of transesophageal echocardiography.

22 graphy, was not cost-effective compared with transesophageal echocardiography.

23 ortening for the measured wall stress, using transesophageal echocardiography.

24 at account for the mobile components seen on transesophageal echocardiography.

25 disease of the thoracic aorta as defined by transesophageal echocardiography.

26 nd geometry of the regurgitant jets by using transesophageal echocardiography.

27 , 4D flow metrics were compared with Doppler transesophageal echocardiography.

28 egree of TA enlargement as assessed using 3D transesophageal echocardiography.

29 nts at the 6-month follow-up as evaluated by transesophageal echocardiography.

30 greatest with type II or III microbubbles on transesophageal echocardiography.

31 lvular dimensions by real-time 3-dimensional-transesophageal-echocardiography.

32 erwent MDCT in addition to transthoracic and transesophageal echocardiography 1 to 3 months post-TAVR

33 ll of them were receiving APT at the time of transesophageal echocardiography (10.2% versus 0% if OAC

34 dentifying the risk for EEs compared with 2D transesophageal echocardiography (2DTEE).

35 4C view was smaller than when measured by 3D-transesophageal echocardiography (3.90+/-0.63 versus 4.3

36 o assess RVOT morphology using 3-dimensional transesophageal echocardiography (3D TEE).

37 o had undergone cardiac CT and 3-dimensional transesophageal echocardiography (3D-TEE) were retrospec

38 completed Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE) clinical trial.

39 The Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE) multicenter stu

40 The Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE) trial found no

41 In 16 patients, transesophageal echocardiography after 30 days confirmed

42 relatively higher in patients evaluated with transesophageal echocardiography after a cerebral ischem

43 Transesophageal echocardiography allows a detailed evalu

44 ly significant aortic atherosclerosis (using transesophageal echocardiography and aortic ultrasound)

45 Transesophageal echocardiography and balloon interrogati

46 e, that can be detected by transthoracic and transesophageal echocardiography and by cardiac magnetic

47 , the valve function remained unchanged, and transesophageal echocardiography and computed tomography

48 e use of ultrasonographic techniques such as transesophageal echocardiography and contrast transcrani

49 Follow-up consisted of sequential transesophageal echocardiography and fluoroscopy as well

50 er general anesthesia and with guidance from transesophageal echocardiography and fluoroscopy.

51 The device was placed with the help of transesophageal echocardiography and fluoroscopy.

52 ortic atheromas (as seen with intraoperative transesophageal echocardiography and intraoperative epia

53 Transesophageal echocardiography and magnetic resonance

54 n 85% of patients as documented by follow-up transesophageal echocardiography and MDCT.

55 Patients underwent transthoracic and transesophageal echocardiography and multidetector compu

56 cipated stent landing zone with simultaneous transesophageal echocardiography and pulmonary venograph

57 matched healthy volunteers underwent initial transesophageal echocardiography and rheumatologic evalu

58 We performed transesophageal echocardiography and rheumatologic evalu

59 araminol and confirmation by bubble-contrast transesophageal echocardiography and right heart cathete

60 technology, including live three-dimensional transesophageal echocardiography and single-beat three-d

61 Accordingly, the agreement was weak between transesophageal echocardiography and Surviving Sepsis Ca

62 Although transesophageal echocardiography and Surviving Sepsis Ca

63 Agreement for treatment decision between transesophageal echocardiography and Surviving Sepsis Ca

64 MV annular geometry with 3-dimensional (3D) transesophageal echocardiography and the association of

65 ging techniques that facilitate BMV, such as transesophageal echocardiography and the recently develo

66 k factors, aortic atherosclerosis (imaged by transesophageal echocardiography) and aortic valve abnor

67 deployment and <5 mm leak by post-procedure transesophageal echocardiography), and no major complica

68 each dose by invasive hemodynamic measures, transesophageal echocardiography, and blood analysis.

69 c balloon, counter pulsation, and the use of transesophageal echocardiography, and improved intra-ope

70 ent of 2 sonomicrometers on the left atrium, transesophageal echocardiography, and invasive hemodynam

71 rease of RV free wall thickness, measured by transesophageal echocardiography, and of RV weight/body

72 ombus, quality of life after stroke, cost of transesophageal echocardiography, and specificity of tra

73 Direct measurement of atrial velocity by transesophageal echocardiography appears to be useful fo

74 tomography, magnetic resonance imaging, and transesophageal echocardiography are reliable tools for

75 scanners in trauma centers limits the use of transesophageal echocardiography as a first-line diagnos

76 Transesophageal echocardiography assessed the degree of

77 A second transesophageal echocardiography assessment (T2) was per

78 Inotropes were prescribed based on transesophageal echocardiography assessment in 14 patien

79 ing and inotropic support derived from early transesophageal echocardiography assessment of hemodynam

80 Transesophageal echocardiographies at baseline, one, and

81 We performed intraoperative transesophageal echocardiography at the insertion and ex

82 ifice area (53%) measured with 3-dimensional transesophageal echocardiography, at 6.05 cm(2) and 0.63

83 tforms of transthoracic echocardiography and transesophageal echocardiography, because hardware and s

84 esults were correlated with transthoracic or transesophageal echocardiography, blood cultures, and th

85 patients with S. aureus bacteremia for whom transesophageal echocardiography can be safely avoided h

86 Transesophageal echocardiography can further delineate t

87 Transesophageal echocardiography can have many helpful u

88 Transesophageal echocardiography can identify low-risk g

89 Transesophageal echocardiography can safely be performed

90 d on primary key words: 3D echocardiography, transesophageal echocardiography, cardiac surgery, and/o

91 Transesophageal echocardiography confirms procedural suc

92 The modern imaging techniques of transesophageal echocardiography, CT, and MRI are report

93 plantation, comprehensive 3-dimensional (3D) transesophageal echocardiography data were acquired for

94 Both transthoracic and transesophageal echocardiography delineate vegetation lo

95 Transesophageal echocardiography demonstrated all closur

96 Transesophageal echocardiography detected incomplete LAA

97 Although transesophageal echocardiography diagnosis of aortic tra

98 of subjects with ASA and cerebral ischemia, transesophageal echocardiography did not detect an alter

99 m, which makes diagnosis by transthoracic or transesophageal echocardiography difficult.

100 ient had anemia and only three patients with transesophageal echocardiography documented left ventric

101 Significant advances in transesophageal echocardiography, electron beam computed

102 Three-dimensional transesophageal echocardiography enables assessment of a

103 he Edwards SAPIEN and had intraprocedural 3D transesophageal echocardiography evaluation of the mitra

104 in studies using invalid controls, unblinded transesophageal echocardiography examinations, and data

105 We examined whether high-risk transesophageal echocardiography features are seen more

106 Transesophageal echocardiography features such as PFO si

107 The association of these transesophageal echocardiography features with other mar

108 n Cryptogenic Stroke Study (PICSS) evaluated transesophageal echocardiography findings in patients en

109 iography findings did not predict subsequent transesophageal echocardiography findings of endocarditi

110 Transesophageal echocardiography follow-up revealed that

111 Among 63 patients with acute closure and transesophageal echocardiography follow-up, there were 3

112 ned transmural myocardial biopsies guided by transesophageal echocardiography from patients with isch

113 rhagic events was significantly lower in the transesophageal-echocardiography group (18 events [2.9 p

114 ive embolic events among 619 patients in the transesophageal-echocardiography group [0.8 percent]) vs

115 Patients in the transesophageal-echocardiography group also had a shorte

116 Transesophageal echocardiography guidance decreased from

117 parable to those on warfarin with or without transesophageal echocardiography guidance.

118 olytic therapy sessions were performed under transesophageal echocardiography guidance.

119 Transesophageal echocardiography-guided beating-heart MV

120 aortic annular sizing using a traditional 2D transesophageal echocardiography-guided or a novel CT-gu

121 Transesophageal echocardiography has also become more us

122 Transesophageal echocardiography has been increasingly p

123 Recently, transesophageal echocardiography has been shown to be a

124 ring the last 6 years, the increasing use of transesophageal echocardiography has shown that atherosc

125 and found to have mobile aortic atheroma on transesophageal echocardiography have a high incidence o

126 Recently, computed tomography and transesophageal echocardiography have been used for seri

127 rative management as follows: intraoperative transesophageal echocardiography; hypothermic circulator

128 Transesophageal echocardiography identified well-organiz

129 Procedural transesophageal echocardiography imaging was reviewed fo

130 9) or atrial fibrillation (n = 44) underwent transesophageal echocardiography immediately before and

131 in question since the advent of ultrasound (transesophageal echocardiography), improvements in magne

132 47 patients, LAA thrombus was identified on transesophageal echocardiography in 10 (21%) patients (O

133 TAD was also measured using 3D-transesophageal echocardiography in 183 patients (long a

134 We performed transesophageal echocardiography in 255 patients with fi

135 ed, and ventricular function was assessed by transesophageal echocardiography in 26 donors before hea

136 ons of the thoracic aorta were measured with transesophageal echocardiography in 373 subjects partici

137 We performed transesophageal echocardiography in 43 patients and acqu

138 We performed transesophageal echocardiography in 47 consecutive, nona

139 l examined using echocardiography, including transesophageal echocardiography in 74% of the cases.

140 The value of precordial or transesophageal echocardiography in addition to clinical

141 s cost $9000 per quality-adjusted life-year; transesophageal echocardiography in all patients cost $1

142 Physicians should consider doing transesophageal echocardiography in all patients with ne

143 o review the perioperative use of noncardiac transesophageal echocardiography in anesthesiology and t

144 Anesthesiologists are increasingly using transesophageal echocardiography in both cardiac and non

145 To demonstrate the applicability of transesophageal echocardiography in clinical practice, t

146 Routine use of intraoperative transesophageal echocardiography in major thoracic surge

147 New research on the use of transesophageal echocardiography in patients with stroke

148 d to identify studies addressing the role of transesophageal echocardiography in S. aureus bacteremia

149 k on the use of computed tomography (CT) and transesophageal echocardiography in screening for and fa

150 355 age- and sex-matched patients undergoing transesophageal echocardiography in search of a cardiac

151 alue of CMR as compared to transthoracic and transesophageal echocardiography in the diagnostic evalu

152 The role of transesophageal echocardiography in the evaluation of AS

153 ients, LAA emptying velocity was measured by transesophageal echocardiography in the setting of pharm

154 Such invasive imaging tools include transesophageal echocardiography, intracardiac echocardi

155 ntrast detected within the thoracic aorta by transesophageal echocardiography is a common and importa

156 Transesophageal echocardiography is a safe procedure tha

157 Transesophageal echocardiography is a useful technique f

158 disease of the thoracic aorta as defined by transesophageal echocardiography is associated with a hi

159 ng right-to-left shunts in settings in which transesophageal echocardiography is not desirable.

160 Transesophageal echocardiography is recognized as more s

161 Measurement of pericardial thickness with transesophageal echocardiography is reproducible and sho

162 Transesophageal echocardiography is the modality of choi

163 acquire full-volume real-time 3-dimensional transesophageal echocardiography loops in 11 normal subj

164 undergoing cardiac surgery, we recorded with transesophageal echocardiography mitral valve early (E)

165 Real-time 3-dimensional transesophageal echocardiography of the mitral valve was

166 Real-time 3-dimensional transesophageal echocardiography of the mitral valve was

167 rior vena cava diameter (SVC) measured using transesophageal echocardiography, of inferior vena cava

168 Full-volume real-time 3-dimensional transesophageal echocardiography offers a unique opportu

169 iography in clinical practice, the effect of transesophageal echocardiography on the cardiac surgical

170 o either treatment guided by the findings on transesophageal echocardiography or conventional treatme

171 ort function by either direct visualization, transesophageal echocardiography, or atrioventricular ve

172 s problem, some trauma centers have used CT, transesophageal echocardiography, or both, in their diag

173 raphy (10.2% versus 0% if OAC at the time of transesophageal echocardiography, P=0.151).

174 as the only indication for anticoagulation, transesophageal echocardiography performed only in patie

175 presenting with neurologic events, in which transesophageal echocardiography plays an important role

176 institution routinely had an intraoperative transesophageal echocardiography, prospectively quantifi

177 terization are feasible and, guided by fetal transesophageal echocardiography, provide potential alte

178 Transesophageal echocardiography provides a highly accur

179 Transesophageal echocardiography provides complementary

180 Transthoracic and transesophageal echocardiography provides complementary

181 Real-time 3-dimensional transesophageal echocardiography provides insights into

182 Thus, real-time 3-dimensional transesophageal echocardiography provides new insights t

183 ze and function of the ventricles as seen on transesophageal echocardiography, renal function and sur

184 It has been proposed that if transesophageal echocardiography reveals no atrial throm

185 We found no evidence that the proposed transesophageal echocardiography risk markers of large P

186 d the feasibility of real-time 3-dimensional transesophageal echocardiography (RT3DTEE) in determinin

187 st few decades, the effect of intraoperative transesophageal echocardiography's (TEE) influence on pe

188 s, including transthoracic echocardiography, transesophageal echocardiography, sequential approaches,

189 The superior resolution achieved with transesophageal echocardiography should allow better per

190 Transesophageal echocardiography should be considered in

191 Transesophageal echocardiography should be proposed in m

192 d for oral anticoagulation if pre-procedural transesophageal echocardiography shows good device posit

193 ass when aortic arch atheromas are seen with transesophageal echocardiography (six times the general

194 d MR, whereupon biplane videofluoroscopy and transesophageal echocardiography studies were repeated.

195 The present 3-dimensional (3D) transesophageal echocardiography study aimed to elucidat

196 ntricular systolic dysfunction, unremarkable transesophageal echocardiography study consistent with s

197 rade graft perfusion, and the uniform use of transesophageal echocardiography substantially decrease

198 75 to 0.84] vs. 85% [95% CI: 0.81 to 0.89]), transesophageal echocardiography (TEE) (89% [95% CI: 0.8

199 We studied 19 patients undergoing BMV using transesophageal echocardiography (TEE) (Chicago, Illinoi

200 o model and quantify the aortic root from 3D transesophageal echocardiography (TEE) and computed tomo

201 LAA closure was confirmed with transesophageal echocardiography (TEE) and contrast fluo

202 The goal of this study was to compare transesophageal echocardiography (TEE) and intracardiac

203 nclude transthoracic echocardiography (TTE), transesophageal echocardiography (TEE) and transcranial

204 Cardiac catheterization and transesophageal echocardiography (TEE) are currently use

205 lue of cardiac CT for detection of DRT using transesophageal echocardiography (TEE) as the reference

206 of aortic stenosis include transthoracic and transesophageal echocardiography (TEE) as well as transv

207 ght (28%) of 136 patients had intraoperative transesophageal echocardiography (TEE) before CABG, and

208 Screening for atrial thrombi with transesophageal echocardiography (TEE) before cardiovers

209 Subsequent studies suggest that 3D transesophageal echocardiography (TEE) can also accurate

210 whether quantitation of thrombus burden with transesophageal echocardiography (TEE) can help risk-str

211 We hypothesize that pre-MVRep transesophageal echocardiography (TEE) can predict postr

212 We analyzed clinical, transthoracic and transesophageal echocardiography (TEE) data in 23 patien

213 spite a normal transthoracic echocardiogram, transesophageal echocardiography (TEE) detected a large

214 ated the associations between cardiac CT and transesophageal echocardiography (TEE) findings and adve

215 atrial spontaneous echo contrast (LASEC) by transesophageal echocardiography (TEE) has been proposed

216 Over the last decade, focused transesophageal echocardiography (TEE) has been proposed

217 Valve excrescences detected by transesophageal echocardiography (TEE) have been conside

218 ler transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE) have reduced hemo

219 Performing transesophageal echocardiography (TEE) in all patients w

220 Hemodynamic monitoring using transesophageal echocardiography (TEE) in patients with

221 me (RT) 3-dimensional (3D) transthoracic and transesophageal echocardiography (TEE) in the evaluation

222 Transesophageal echocardiography (TEE) is an integral pa

223 The use of two-dimensional (2D) transesophageal echocardiography (TEE) is nearly univers

224 Transesophageal echocardiography (TEE) is the diagnostic

225 Transesophageal echocardiography (TEE) is the gold stand

226 nsecutive post-LAAEI patients with follow-up transesophageal echocardiography (TEE) performed in sinu

227 t" jet could be identified on the postbypass transesophageal echocardiography (TEE) study in only 1 p

228 The purpose of this study was to use transesophageal echocardiography (TEE) to define the mec

229 This study used 3D transesophageal echocardiography (TEE) to determine the

230 We developed a method of transesophageal echocardiography (TEE) to evaluate murin

231 Despite the widespread use of transesophageal echocardiography (TEE) to guide structur

232 pared cross-sectional three-dimensional (3D) transesophageal echocardiography (TEE) to two-dimensiona

233 Transesophageal echocardiography (TEE) was performed in

234 Pulsed-wave Doppler transesophageal echocardiography (TEE) was performed wit

235 Biplane videofluoroscopy and transesophageal echocardiography (TEE) were performed (o

236 clinical probability of the disease and (2) transesophageal echocardiography (TEE) would be most use

237 TTE contrast study and the gold standard, of transesophageal echocardiography (TEE), and assessed its

238 These lesions can be observed easily with transesophageal echocardiography (TEE), but the accuracy

239 ardiography, particularly the development of transesophageal echocardiography (TEE), have revolutioni

240 f uncorrected MR, measured by intraoperative transesophageal echocardiography (TEE), in CABG patients

241 Echocardiography, particularly transesophageal echocardiography (TEE), is a vital diagn

242 tify patients with LA thrombus, diagnosed by transesophageal echocardiography (TEE), who were in SR d

243 A transesophageal echocardiography (TEE)-guided strategy h

244 study was to compare the relative cost of a transesophageal echocardiography (TEE)-guided strategy v

245 enter study was a prospective trial in which transesophageal echocardiography (TEE)-guided treatment

246 re is most successful by assessing them with transesophageal echocardiography (TEE).

247 ent between ICE and simultaneously performed transesophageal echocardiography (TEE).

248 rgitation (PPR) identified by intraoperative transesophageal echocardiography (TEE).

249 valuated the accuracy of VC imaging of AR by transesophageal echocardiography (TEE).

250 descending thoracic aorta in comparison with transesophageal echocardiography (TEE).

251 0 patients with aortic plaques identified by transesophageal echocardiography (TEE).

252 ft ventricular systolic function by means of transesophageal echocardiography (TEE).

253 connection can be made with confidence using transesophageal echocardiography (TEE).

254 ebral ischemia undergoing investigation with transesophageal echocardiography (TEE).

255 age 67 years, range 29 to 86) who underwent transesophageal echocardiography (TEE).

256 itially positioned by use of fluoroscopy and transesophageal echocardiography (TEE).

257 and mobile "aortic debris" imaged in vivo by transesophageal echocardiography (TEE).

258 ood pressure, electrocardiography (EKG), and transesophageal echocardiography (TEE).

259 tion (AF) ablation, attributed to the use of transesophageal echocardiography (TEE).

260 nsmural myocardial biopsies (n=37) guided by transesophageal echocardiography to determine the extent

261 re and after tightening of each STRING using transesophageal echocardiography to grade IMR.

262 The use of transesophageal echocardiography to guide the management

263 The use of transesophageal echocardiography to identify PFO was per

264 -matched control subjects underwent protocol transesophageal echocardiography to image the mitral val

265 etal cardiac catheterization guided by fetal transesophageal echocardiography to provide alternative

266 ce was inserted into the heart and guided by transesophageal echocardiography to the ventricular surf

267 By transesophageal echocardiography, total MR was reduced t

268 A 5.5/7.5-MHz biplanar transesophageal echocardiography transducer was advanced

269 Forty-four patients selected after transesophageal echocardiography underwent balloon inter

270 tial implantation, as identified by means of transesophageal echocardiography, underwent additional b

271 Transesophageal echocardiography velocities modestly but

272 Transesophageal echocardiography was 86% to 100% sensiti

273 Closure rate as judged by transesophageal echocardiography was 88% initially and 1

274 Pericardial thickness > or = 3 mm on transesophageal echocardiography was 95% sensitive and 8

275 tudies with a total of 4050 patients, use of transesophageal echocardiography was associated with hig

276 ve pericarditis who underwent intraoperative transesophageal echocardiography was compared with peric

277 Precardioversion transesophageal echocardiography was encouraged, particu

278 Transesophageal echocardiography was first performed (T1

279 Transesophageal echocardiography was performed at 45 day

280 For D110, D150, and warfarin, transesophageal echocardiography was performed before 25

281 Transesophageal echocardiography was performed before di

282 Transesophageal echocardiography was performed during fo

283 MV imaging using 3D transesophageal echocardiography was performed in 10 nor

284 Transesophageal echocardiography was performed in 385 su

285 Transesophageal echocardiography was performed in 581 su

286 A transesophageal echocardiography was performed in 74% of

287 Transesophageal echocardiography was used to determined

288 Transesophageal echocardiography was used to evaluate fe

289 Color Doppler transesophageal echocardiography was used to grade MR on

290 echocardiography, alone or in sequence with transesophageal echocardiography, was not cost-effective

291 s draining beyond the cavoatrial junction on transesophageal echocardiography were excluded.

292 cal prosthetic valve dysfunction assessed by transesophageal echocardiography were included in this p

293 sure recordings with simultaneous Doppler by transesophageal echocardiography were obtained from 11 p

294 Biplane videofluoroscopy and transesophageal echocardiography were performed before a

295 Biplane videofluoroscopy and transesophageal echocardiography were performed before a

296 To summarize the use of transesophageal echocardiography when investigating hypo

297 urgitation in group 1 based on postoperative transesophageal echocardiography, whereas group 2 had an

298 Because 3-dimensional transesophageal echocardiography with gated rotational a

299 RECOMMENDATION 5: Both transesophageal echocardiography with short-term prior a

300 Monitored by fetal transesophageal echocardiography, with an 8F or 10F, 10-